Abstract
Analysis of microsatellite TNFa marker and (−308(G/A) polymorphisms in promoter of TNFa gene was conducted in 167 patients with various types of sporadic breast cancer (BC) as well as in 139 healthy Russian donors. It was shown that frequency of allele 7 in TNFa microsatellite marker was significantly higher in BC patients than in healthy donors (17.9% versus 10.4%; P = 0.02) mainly due to the patients with invasive ductal BC (19.2% versus 10.4%; P = 0.008). The TNFa allele 9 was observed significantly more frequently in patients with invasive-ductal cancer (6.4% versus 1%; p = 0.01). The studies of −308(G/A)TNFα polymorphism in BC patients and healthy donors have shown no differences in the distribution frequency of highly secreted allele (−308A)TNFα. However, invasive lobular BC patients carrying (−308AG)TNFα genotype were observed significantly more frequently than invasive-ductal BC patients carrying the same allele (34.0 versus 17.3%; P = 0.034). Thus it has been shown for the first time that invasive-ductal and invasive-lobular BC patients differ in distribution of TNFa and −308(G/A)TNFα alleles.
Similar content being viewed by others
References
Parkin, D.M., International Variations, Oncogene, 2002, vol. 23, no. 38, pp. 6329–6340.
Zhao, H., Langerod, A., Ji, Y., et al., Different Gene Expression Patterns in Invasive Lobular and Ductal Carcinomas of the Breast, Mol. Biol. Cell, 2004, vol. 15, pp. 2523–2536.
Nelson, H.D., Huffman, L.H., Fu, R., et al., Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review for the US Preventive Services Task Force, Ann. Int. Med., 2005, vol. 143, no. 5, pp. 362–379.
Albrektsen, G., Heuch, I., Thoresen, S., and Kvale, G., Family History of Breast Cancer and Short-Term Effects of Childbirths on Breast Cancer Risk, Int. J. Cancer, 2006, vol. 119, no. 6, pp. 1468–1474.
Dunning, A.M., Healey, C.S., Pharoah, P.D., et al., A Systematic Review of Genetic Polymorphisms and Breast Cancer Risk, Cancer Epidemiol. Biomarkers Prevention, 1999, vol. 8, no. 10, pp. 843–854.
Balkwill, F., Tumor Necrosis Factor or Tumor Promoting Factor?, Cytokine Growth Factor Rev., 2002, vol. 13, no. 2, pp. 135–141.
Hagemann, T., Wilson, J., Kulbe, H., et al., Macrophages Induce Invasiveness of Epithelial Cancer Cells via NF-Kappa B and JNK, J. Immunol., 2005, vol. 175, pp. 1197–1205.
Rubio, M.F., Werbajh, S., Cafferata, E.G., et al., TNF-Alpha Enhances Estrogen-Induced Cell Proliferation of Estrogen-Dependent Breast Tumor Cells through a Complex Containing Nuclear Factor-Kappa B, Oncogene, 2006, vol. 25, no. 9, pp. 1367–1377.
Seeger, H., Wallwiener, D., and Mueck, A.O., Different Effects of Estradiol and Various Antiestrogens on TNF-Alpha-Induced Changes of Biochemical Markers for Growth and Invasion of Human Breast Cancer Cells, Life Sci., 2006, vol. 78, no. 13, pp. 1464–1468.
Hajeer, A.H. and Hutchinson, I.V., Influence of TNF Alfa Gene Polymorphism on TNF Alfa Production and Disease, Hum. Immunol., 2001, vol. 62, no. 11, pp. 1191–1199.
Mestiri, S., Bouaouina, N., Ahmed, S.B., et al., Genetic Variation in the Tumor Necrosis Factor-Alpha Promoter Region and in the Stress Protein hsp70-2: Susceptibility and Prognostic Implications in Breast Carcinoma, Cancer, 2001, vol. 91, no. 4, pp. 672–678.
Kamali-Sarvestani, E., Merat, A., and Talei, A.R., Polymorphism in the Genes of Alpha and Beta Tumor Necrosis Factors (TNF-Alpha and TNF-Beta) and Gamma Interferon (IFN-Gamma) among Iranian Women with Breast Cancer, Cancer Lett., 2005, vol. 223, no. 1, pp. 113–119.
Giordany, L., Bruzzi, P., Lasalandra, C., et al., Association of Breast Cancer and Polymorphisms of Interleukin-10 and Tumor Necrosis Factor-α Genes, Clinic. Chem., 2003, vol. 49, no. 10, pp. 1664–1667.
Azmy, I.A., Balasubramanion, S.P., Wilson, A.G., et al., Role of Tumor Necrosis Factor Gene Polymorphisms (−308 and −238) in Breast Cancer Susceptibility and Severity, Breast Cancer Res., 2004, vol. 6, no. 4, pp. 395–400.
Smith, K.C., Bateman, A.C., Fussell, H.M., and Howell, W.M., Cytokine Gene Polymorphisms and Breast Cancer Susceptibility and Prognosis, Eur. J. Immunogenet., 2004, vol. 31, no. 4, pp. 167–173.
Scola, L., Vaglica, M., Crivello, A., et al., Cytokine Gene Polymorphisms and Breast Cancer Susceptibility, Ann. N.Y. Acad. Sci., 2006, vol. 1089, pp. 104–109.
Nedospasov, S.A., Udalova, I.A., Kuprash, D.V., and Turetskaya, R.L., DNA Sequence Polymorphism at the Human Tumor Necrosis Factor (TNF) Locus: Numerous TNF/Lymphotoxin Alleles Tagged by Two Closely Linked Microsatellites in the Upstream Region of the Lymphotoxin (TNF-Beta) Gene, J. Immunol., 1991, vol. 147, no. 3, pp. 1053–1059.
Perrey, C., Turner, S.J., Pravica, V., et al., ARMS-PCR Methodologies to Determine IL-10, TNF-Alpha, TNF-Beta and TGF-Beta 1 Gene Polymorphisms, Transplant. Immunol., 1999, vol. 7, no. 2, pp. 127–128.
de Jong, M.M., Nolte, I.M., de Vries, E.G., et al., The HLA Class III Subregion Is Responsible for an Increased Breast Cancer Risk, Hum. Mol. Genet., 2003, vol. 12, no. 18, pp. 2311–2319.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © A.S. Ostashkin, T.F. Malivanova, V.A. Yurchenko, N.N. Mazurenko, 2008, published in Genetika, 2008, Vol. 44, No. 9, pp. 1276–1280.
Rights and permissions
About this article
Cite this article
Ostashkin, A.S., Malivanova, T.F., Yurchenko, V.A. et al. Tumor necrosis factor gene polymorphisms in breast cancer patients. Russ J Genet 44, 1111–1115 (2008). https://doi.org/10.1134/S1022795408090159
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1022795408090159